Vialwirebiotech, curated
November 21, 2026, 3:54 PM
July 28, 2026
- 12:00 PM · BioWorld12:00 PMEpitel raises $26M for wireless EEG system for seizure monitoring — BioWorld
- 12:00 PM · BioWorld12:00 PMKolon Tissuegene shares fall as TG-C misses knee OA endpoints — BioWorld
- 12:00 PM · BioWorld12:00 PMAltimmune on PEth to phase III in AUD with pemvi — BioWorld
- 12:00 PM · BioWorld12:00 PMAmgen makes its case for hearing to keep Tavneos on the US market — BioWorld
- 11:00 AM · SCMP — Tech11:00 AMRecord Chinese biotech out-licensing meets rising US scrutiny — SCMP — Tech
- 9:19 AM · TechCrunch9:19 AMRecursive Superintelligence signs $410 compute deal with Amazon — TechCrunch
- 9:00 AM · BioWorld9:00 AMShanghai Escugen Biotechnology reports new TROP2-targeting ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMAscletis Pharma’s ASC-37 shows weight loss in DIO mice — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMDYNE-302 gets IND for facioscapulohumeral muscular dystrophy — BioWorld
- 9:00 AM · BioWorld9:00 AMSuven Life Sciences divulges new muscarinic M4 receptor PAMs — BioWorld
- 9:00 AM · BioWorld9:00 AMDecoy’s D-MAV shows in vitro activity against Zaire Ebola virus — BioWorld
- 9:00 AM · BioWorld9:00 AMShanghai Jeyou Pharmaceutical identifies new DHX9 inhibitors — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMPromatix advances PBS-293-exatecan with Innovate UK grant — BioWorld
- 9:00 AM · BioWorld9:00 AMBiomarin and n-Lorem partner on ASO for ReNU syndrome — BioWorld
- 8:00 AM · BioPharma Dive8:00 AMAn eye drug biotech banks $118M and stocks its executive suite — BioPharma Dive
- 7:29 AM · SCMP — Tech7:29 AMHong Kong drives trials for breast cancer, eye treatments across Greater Bay Area — SCMP — Tech
- 7:27 AM · FT — Pharmaceuticals7:27 AMGSK to shut historic Stevenage hub as it announces £1.9bn cost-saving drive — FT — Pharmaceuticals
- 6:00 AM · STAT News
- 5:54 AM · SCMP — Tech5:54 AMTop Los Angeles diabetes doctor Shen Yang joins China’s Westlake University — SCMP — Tech
- 5:00 AM · Drug Discovery World5:00 AMPhase III trials confirm benefits of Lilly’s triple agonist retatrutide — Drug Discovery World
- 1:10 AM · Science (News)1:10 AMActivists and leaders at global HIV meeting decry price of prevention drug — Science (News)
July 27, 2026
- 12:00 PM · BioWorld12:00 PMMaplight aims to differentiate muscarinic agonist from competitors — BioWorld
- 12:00 PM · BioWorld12:00 PMTidalsense raises $19M for AI-powered COPD diagnostic platform — BioWorld
- 10:16 AM · BioPharma Dive10:16 AMSarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO — BioPharma Dive
- 9:46 AM · Pharmaceutical Executive9:46 AM<![CDATA[FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMAlmirall and Certest Biotec establish derma collaboration — BioWorld
- 9:00 AM · BioWorld9:00 AMKelun-Biotech’s SKB-565 cleared to enter clinic in China — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMAlzecure Pharma patents new UGT1A1 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMBetta Pharmaceuticals reports new KRAS degradation inducers — BioWorld
- 9:00 AM · BioWorld9:00 AMInnovstone Therapeutics discloses new cathepsin C inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMCamp4 Therapeutics’ lead ASO approved for clinical trials in Australia — BioWorld
- 9:00 AM · BioWorld9:00 AMExeliris and Lin Gang Laboratory identify new PI3Kα inhibitors — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMVeraxa Biotech advances bispecific ADC from Omniab collaboration — BioWorld
- 8:00 AM · STAT News
- 6:13 AM · Pharmaceutical Technology6:13 AMOutlook Therapeutics wins FDA approval for Lytenava in wet AMD — Pharmaceutical Technology
- 6:00 AM · Drug Discovery World6:00 AMLeriglitazone gets positive EU opinion for rare neurodegenerative disease — Drug Discovery World
- 5:23 AM · Pharmaceutical Technology5:23 AMBiointron introduces RushData platform for AI-driven antibody discovery — Pharmaceutical Technology
- 4:58 AM · Pharmaceutical Technology4:58 AMKenvue’s Tylenol with Naproxen gains FDA approval — Pharmaceutical Technology
- 3:26 AM · STAT News3:26 AMSTAT+: Argenx to buy Forte Biosciences for $2.2B — STAT News